CHMP PROM minutes for the meeting on 15 July 2024
Submitted by Anonymous (not verified) on 2 October 2024 - 15:10
CHMP PROM minutes for the meeting on 15 July 2024
Human medicines European public assessment report (EPAR): SomaKit TOC, edotreotide, Date of authorisation: 08/12/2016, Revision: 18, Status: Authorised
Submitted by Anonymous (not verified) on 2 October 2024 - 14:52
Human medicines European public assessment report (EPAR): SomaKit TOC, edotreotide, Date of authorisation: 08/12/2016, Revision: 18, Status: Authorised
Human medicines European public assessment report (EPAR): Locametz, gozetotide, Date of authorisation: 09/12/2022, Revision: 5, Status: Authorised
Submitted by Anonymous (not verified) on 2 October 2024 - 14:48
Human medicines European public assessment report (EPAR): Locametz, gozetotide, Date of authorisation: 09/12/2022, Revision: 5, Status: Authorised
Human medicines European public assessment report (EPAR): Ilumetri, tildrakizumab, Date of authorisation: 17/09/2018, Revision: 13, Status: Authorised
Submitted by Anonymous (not verified) on 2 October 2024 - 14:37
Human medicines European public assessment report (EPAR): Ilumetri, tildrakizumab, Date of authorisation: 17/09/2018, Revision: 13, Status: Authorised
Improving efficiency of approval process for new medicines in the EU
Submitted by Anonymous (not verified) on 2 October 2024 - 14:00
Improving efficiency of approval process for new medicines in the EU
EMEA-003059-PIP02-23
Submitted by Anonymous (not verified) on 2 October 2024 - 13:55
EMEA-003059-PIP02-23
EMEA-003154-PIP01-21
Submitted by Anonymous (not verified) on 2 October 2024 - 13:55
EMEA-003154-PIP01-21
EMEA-002850-PIP03-22
Submitted by Anonymous (not verified) on 2 October 2024 - 13:45
EMEA-002850-PIP03-22
Human medicines European public assessment report (EPAR): Dacogen, decitabine, Date of authorisation: 20/09/2012, Revision: 18, Status: Authorised
Submitted by Anonymous (not verified) on 2 October 2024 - 13:45
Human medicines European public assessment report (EPAR): Dacogen, decitabine, Date of authorisation: 20/09/2012, Revision: 18, Status: Authorised
Human medicines European public assessment report (EPAR): Simponi, golimumab, Date of authorisation: 01/10/2009, Revision: 51, Status: Authorised
Submitted by Anonymous (not verified) on 2 October 2024 - 13:18
Human medicines European public assessment report (EPAR): Simponi, golimumab, Date of authorisation: 01/10/2009, Revision: 51, Status: Authorised